Buy KLOW — The 4-Peptide Research Stack for Tissue Repair, Inflammation Control, and Regenerative Research

KLOW is a research-grade, four-peptide blend that combines GHK-Cu, BPC-157, TB-500, and KPV in a single lyophilized formulation. Researchers study it extensively for advanced tissue repair and inflammatory signaling. Consequently, it represents the most comprehensive multi-pathway research stack in the regenerative peptide category.

What Is the KLOW Peptide Blend?

KLOW is a naming convention rather than an acronym, and it identifies a research vial containing four peptides in one formulation. Scientists designed the standard composition as 80mg total: 50mg GHK-Cu, 10mg BPC-157, 10mg TB-500, and 10mg KPV. Moreover, KLOW is essentially the three-peptide GLOW formulation with KPV added, which takes it from a 70mg three-peptide blend to an 80mg four-peptide one.

Researchers investigate multi-component formulations because biological systems rarely operate through a single pathway. Therefore, each component in the KLOW research blend contributes a distinct, well-documented mechanism.

The Four Peptides Inside KLOW

GHK-Cu — 50mg

GHK-Cu is a copper-binding tripeptide built from glycine, histidine, and lysine, wrapped around a copper ion. Research attention focuses mostly on the extracellular matrix, where investigators study collagen-related signaling, fibroblast activity, and tissue remodeling at the matrix level. Notably, genomic analysis has reported that GHK-Cu influences the expression of more than 4,000 human genes.

BPC-157 — 10mg

BPC-157 is a synthetic pentadecapeptide (15 amino acids, CAS 137525-51-0) derived from a sequence found in gastric proteins. Preclinical literature examines it in tissue-repair and angiogenesis contexts, particularly through VEGFR2-mediated signaling and fibroblast migration pathways.

TB-500 — 10mg

TB-500 is a synthetic fragment of Thymosin Beta-4, studied for cell migration and structural remodeling. It operates through actin sequestration and cytoskeletal remodeling, which lowers the polymerization threshold to prime cellular migration and endothelial cell movement in recovery models.

KPV — 10mg

KPV is a tiny tripeptide, lysine-proline-valine, that matches the tail end of alpha-melanocyte-stimulating hormone. Researchers study it in inflammatory and barrier-related pathways, and it acts independently of melanocortin receptors. Consequently, KPV does not trigger the pigmentary effects associated with full-length α-MSH.

How Does the KLOW Blend Work?

The blend layers four stages of the tissue rebuild and inflammation-control process.

• GHK-Cu builds the structural and collagen foundation

• BPC-157 supports localized vascular and repair signaling

• TB-500 drives systemic cell migration toward injury sites

• KPV controls the inflammatory signaling that can impede recovery

This mechanistic layering is why researchers frequently examine KLOW in advanced healing, gut-barrier support, and inflammation research protocols.

Key Research Applications

Researchers study KLOW across a broad range of preclinical repair and inflammation models.

• Extracellular matrix and collagen-related signaling investigations

• Tissue repair and angiogenesis-related research

• Cell migration and structural remodeling studies

• Inflammatory and immune-related signaling pathways

• Gut-barrier support and colitis-associated research models

• Skin quality and dermal architecture investigations

Product Specifications

When you Buy KLOW from our catalog, you receive a single-vial lyophilized blend at 80mg total (GHK-Cu 50mg / BPC-157 10mg / TB-500 10mg / KPV 10mg) as a sterile powder for reconstitution.

We test every batch independently to ≥99% purity by HPLC, and we confirm identity through third-party mass spectrometry. In addition, each batch undergoes LAL endotoxin testing, heavy metals screening, and microbial limit testing. We include batch-specific Certificates of Analysis for full research transparency.

Frequently Asked Questions

What is KLOW used for in research?

Researchers use KLOW in laboratory studies of tissue repair, extracellular matrix remodeling, cell migration, inflammatory signaling, and gut-barrier support. However, it is not approved for human or veterinary use in any jurisdiction.

How should I store KLOW?

Store the lyophilized vial at −20°C in a desiccated environment and protect it from light. After reconstitution, refrigerate the solution at 2–8°C and avoid repeated freeze-thaw cycles.

What purity should I expect?

We test every batch to ≥99% purity by HPLC. We ship a batch-specific Certificate of Analysis with each order, and it covers HPLC purity, mass spectrometry identity, endotoxin levels, and heavy metals screening.

What is the difference between KLOW and GLOW?

KLOW is GLOW plus KPV. Whereas GLOW contains GHK-Cu, BPC-157, and TB-500 at 70mg total, KLOW adds 10mg of KPV for an 80mg total, which introduces an inflammation-control layer.

Is KLOW a stack or a blend?

Suppliers list KLOW both ways. A blend means the compounds are co-lyophilized into a single vial, while a stack means separate vials per compound. Consequently, always confirm the format before ordering.

Important Research Disclaimer

This product is intended strictly for laboratory research use only. It is not for human or veterinary use, and not for diagnostic or therapeutic applications. As of 2026, KLOW remains an unapproved investigational peptide blend with no FDA-approved indication, and no clinical trial has evaluated the four-component combination itself. Therefore, no one outside an institutional research setting should handle or use KLOW. Qualified researchers should handle all peptides in accordance with institutional safety guidelines and applicable regulations.

Ready to Advance Your Regenerative Research?

Buy KLOW today and join laboratories worldwide that rely on verified purity, batch-level transparency, and U.S.-made quality.